Patents Assigned to Gemin X Biotechnologies Inc.
-
Publication number: 20080280896Abstract: The present invention relates to novel Dipyrrole Compounds, compositions comprising a Dipyrrole Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Dipyrrole Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus. The invention also provides screening assays for compounds that can be used in combination with Dipyrrole Compounds for the treatment of cancer or neoplastic disease, inhibition of cancer cell growth, or treatment of viral infections.Type: ApplicationFiled: December 22, 2005Publication date: November 13, 2008Applicant: GEMIN X BIOTECHNOLOGIES INC.Inventors: Giorgio Attardo, Sasmita Triparthy, Elise Rioux, Gerson Gonzalez
-
Publication number: 20080076739Abstract: The present invention relates to methods for treating or preventing arthritis comprising administering a Triheterocyclic Compound. In one embodiment, the present invention relates to methods of using Triheterocyclic Compounds for treating or preventing rheumatoid arthritis comprising administering a Triheterocyclic Compound.Type: ApplicationFiled: August 22, 2007Publication date: March 27, 2008Applicant: Gemin X Biotechnologies Inc.Inventor: Jean Viallet
-
Publication number: 20080051400Abstract: The present invention relates to methods useful for treating or preventing anemia or thrombocytopenia, comprising administrating an effective amount of a Triheterocyclic Compound to a subject in need thereof. The present invention also relates to methods useful for preventing anemia or thrombocytopenia in a subject, comprising administrating an effective amount of a Triheterocyclic Compound to the subject, wherein the subject is at heightened risk of developing anemia or thrombocytopenia.Type: ApplicationFiled: July 5, 2007Publication date: February 28, 2008Applicant: Gemin X Biotechnologies Inc.Inventors: Jean Viallet, Susan O'Brien
-
Publication number: 20070037856Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.Type: ApplicationFiled: October 16, 2006Publication date: February 15, 2007Applicant: Gemin X Biotechnologies Inc.Inventors: Roy Johnson, Giorgio Attardo
-
Patent number: 7144912Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for causing immunosuppression. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing an autoimmune disease.Type: GrantFiled: July 18, 2002Date of Patent: December 5, 2006Assignee: Gemin X Biotechnologies Inc.Inventors: Roy A. Johnson, Giorgio Attardo
-
Publication number: 20040014987Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.Type: ApplicationFiled: March 19, 2003Publication date: January 22, 2004Applicant: Gemin X Biotechnologies Inc.Inventors: Madiraju S.R. Murthy, Nancy A.E. Steenaart, Roy A. Johnson, Gordon C. Shore
-
Patent number: 6602879Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.Type: GrantFiled: April 4, 2002Date of Patent: August 5, 2003Assignee: Gemin X Biotechnologies Inc.Inventors: Madiraju S. R. Murthy, Nancy A. E. Steenaart, Roy A. Johnson, Gordon C. Shore
-
Publication number: 20030119894Abstract: The present invention provides methods for treating or preventing cancer or neoplastic disease comprising administering to a patient a compound having the features of a pharmacophore for human anti-apotptotic Bcl protein inhibitors or identified by the in vitro methods for identifying anti-apotptotic-Bcl protein inhibitors. Also disclosed are methods for inhibiting the growth of a cancer cell or a neoplastic cell, comprising contacting the cancer cell or neoplastic cell with a compound having the features of a pharmacophore for human anti-apoptotic-Bcl protein inhibitors.Type: ApplicationFiled: July 20, 2001Publication date: June 26, 2003Applicant: Gemin X Biotechnologies Inc.Inventors: Madiraju S.R. Murthy, Gordon C. Shore, Jurgen Bajorath, Florence L. Stahura
-
Patent number: 6407244Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.Type: GrantFiled: January 26, 2000Date of Patent: June 18, 2002Assignee: Gemin X Biotechnologies Inc.Inventors: Madiraju S. R. Murthy, Nancy A. E. Steenaart, Roy A. Johnson, Gordon C. Shore